Related Experiment Video
Updated: Apr 30, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.8K
An assessment by the Statin Intolerance Panel: 2014 update
John R Guyton1, Harold E Bays2, Scott M Grundy3
1Division of Endocrinology, Diabetes, and Metabolism, Duke University Medical Center, 201 Trent Drive, Baker House 281, Durham, NC 27710, USA.
Journal of Clinical Lipidology
|May 6, 2014
Summary
This article offers guidance on statin intolerance, emphasizing the clinician
Area of Science:
- Cardiology
- Pharmacology
- Clinical Practice
Background:
- Statin intolerance is a significant barrier to cardiovascular risk reduction.
- Symptomatic adverse effects of statins can hinder patient adherence and treatment efficacy.
- Existing guidelines offer limited specific advice on managing statin intolerance.
Purpose of the Study:
- To provide a framework for understanding statin intolerance.
- To offer general recommendations for health professionals managing statin intolerance.
- To highlight the need for further research into statin intolerance and its management.
Main Methods:
- Review of existing literature and clinical experience by the National Lipid Association Statin Intolerance Panel.
- Development of a conceptual framework for statin intolerance.
- Formulation of general recommendations for clinical practice.
Main Results:
- Symptomatic statin intolerance frequently impedes effective cardiovascular risk reduction.
- Adverse effects from statins rarely result in permanent health issues.
- The advisory role of clinicians is crucial in guiding patient decisions regarding statin tolerability.
Conclusions:
- A structured approach is needed to understand and manage statin intolerance.
- Clinicians should actively engage patients in shared decision-making about statin therapy.
- Further research with robust designs is essential to advance the understanding and treatment of statin intolerance.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
01:26Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
01:27Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495